Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 275

1.

Ascending monoaminergic systems alterations in Alzheimer's disease. translating basic science into clinical care.

Trillo L, Das D, Hsieh W, Medina B, Moghadam S, Lin B, Dang V, Sanchez MM, De Miguel Z, Ashford JW, Salehi A.

Neurosci Biobehav Rev. 2013 Sep;37(8):1363-79. doi: 10.1016/j.neubiorev.2013.05.008. Epub 2013 May 24. Review.

PMID:
23707776
2.

Monoamines tissue content analysis reveals restricted and site-specific correlations in brain regions involved in cognition.

Fitoussi A, Dellu-Hagedorn F, De Deurwaerdère P.

Neuroscience. 2013;255:233-45. doi: 10.1016/j.neuroscience.2013.09.059. Epub 2013 Oct 10.

PMID:
24120557
3.

Monoamine neurocircuitry in depression and strategies for new treatments.

Hamon M, Blier P.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:54-63. doi: 10.1016/j.pnpbp.2013.04.009. Epub 2013 Apr 19. Review.

PMID:
23602950
4.

Short-term atrazine exposure causes behavioral deficits and disrupts monoaminergic systems in male C57BL/6 mice.

Lin Z, Dodd CA, Filipov NM.

Neurotoxicol Teratol. 2013 Sep-Oct;39:26-35. doi: 10.1016/j.ntt.2013.06.002. Epub 2013 Jun 14.

PMID:
23770127
5.

[Synthesis of monoamines by non-monoaminergic neurons: illusion or reality?].

Ugrumov MV.

J Soc Biol. 2009;203(1):75-85. doi: 10.1051/jbio:2009013. Epub 2009 Apr 10. Review. French.

PMID:
19358813
6.

Dopaminergic D2 receptor is a key player in the substantia nigra pars compacta neuronal activation mediated by REM sleep deprivation.

Proença MB, Dombrowski PA, Da Cunha C, Fischer L, Ferraz AC, Lima MM.

Neuropharmacology. 2014 Jan;76 Pt A:118-26. doi: 10.1016/j.neuropharm.2013.08.024. Epub 2013 Sep 4.

PMID:
24012539
7.

Monoaminergic neurotransmitters, their precursors and metabolites in brains of Alzheimer patients.

Storga D, Vrecko K, Birkmayer JG, Reibnegger G.

Neurosci Lett. 1996 Jan 12;203(1):29-32.

PMID:
8742039
8.
9.
11.

Brain region-specific monoaminergic correlates of neuropsychiatric symptoms in Alzheimer's disease.

Vermeiren Y, Van Dam D, Aerts T, Engelborghs S, De Deyn PP.

J Alzheimers Dis. 2014;41(3):819-33. doi: 10.3233/JAD-140309.

PMID:
24685637
13.

Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?

Harrison IF, Dexter DT.

Pharmacol Ther. 2013 Oct;140(1):34-52. doi: 10.1016/j.pharmthera.2013.05.010. Epub 2013 May 24. Review.

PMID:
23711791
14.

Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease.

Reinikainen KJ, Paljärvi L, Halonen T, Malminen O, Kosma VM, Laakso M, Riekkinen PJ.

Neurobiol Aging. 1988 May-Jun;9(3):245-52.

PMID:
3398991
15.

Dopaminergic and serotoninergic deficiencies in young adult rats prenatally exposed to the bacterial lipopolysaccharide.

Wang S, Yan JY, Lo YK, Carvey PM, Ling Z.

Brain Res. 2009 Apr 10;1265:196-204. doi: 10.1016/j.brainres.2009.02.022. Epub 2009 Feb 21.

PMID:
19236855
16.

Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease.

Sparks DL, Hunsaker JC 3rd, Slevin JT, DeKosky ST, Kryscio RJ, Markesbery WR.

Ann Neurol. 1992 Jun;31(6):611-20.

PMID:
1355334
17.

Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus.

Taylor TN, Alter SP, Wang M, Goldstein DS, Miller GW.

Neuropharmacology. 2014 Jan;76 Pt A:97-105. doi: 10.1016/j.neuropharm.2013.08.033. Epub 2013 Sep 8.

18.

Monoaminergic neuropathology in Alzheimer's disease.

Šimić G, Babić Leko M, Wray S, Harrington CR, Delalle I, Jovanov-Milošević N, Bažadona D, Buée L, de Silva R, Di Giovanni G, Wischik CM, Hof PR.

Prog Neurobiol. 2017 Apr;151:101-138. doi: 10.1016/j.pneurobio.2016.04.001. Epub 2016 Apr 12. Review.

PMID:
27084356
19.

Nicotine-induced changes in neurotransmitter levels in brain areas associated with cognitive function.

Singer S, Rossi S, Verzosa S, Hashim A, Lonow R, Cooper T, Sershen H, Lajtha A.

Neurochem Res. 2004 Sep;29(9):1779-92.

PMID:
15453274

Supplemental Content

Support Center